Mark W. Kunkel

Comprehensive characterization of the Published Kinase Inhibitor Set

Jonathan M. Elkins, Vita Fedele, M. Szklarz et al. · Nature Biotechnology · 2015 · 350 citations

Pharmacy, Medicinal Chemistry, Oncology +13

Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression

Eric C. Polley, Mark W. Kunkel, David M. Evans et al. · JNCI Journal of the National Cancer Institute · 2016 · 173 citations · Full text

Medicine, Oncology, Pharmacology +17

Activation of cAMP-dependent protein kinase is required for heterologous desensitization of adenylyl cyclase in S49 wild-type lymphoma cells.

R B Clark, Mark W. Kunkel, Jacqueline Friedman et al. · Proceedings of the National Academy of Sciences · 1988 · 146 citations · Full text

Medicine, Cancer Biology, Pharmacology +13

Mechanisms of Inhibition of the Thioredoxin Growth Factor System by Antitumor 2-Imidazolyl Disulfides

D. Lynn Kirkpatrick, Miles Kuperus, Marla Dowdeswell et al. · Biochemical Pharmacology · 1998 · 139 citations

Life Sciences, Cancer Biology, Oncology +13

Antitumor Activity of Bis-indole Derivatives

Aldo Andreani, Silvia Burnelli, Massimiliano Granaiola et al. · Journal of Medicinal Chemistry · 2008 · 110 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14